Nobel Biocare launches new dental implant

With its unique tip and double-variable thread design, NobelActive condenses bone during insertion unlike conventional self-tapping implants. This bone-condensing capability delivers high initial implant stability, even in compromised bone situations, and can eliminate the need for time-consuming and unpleasant implant procedures for patients, such as bone-grafting. The bone-condensing property and apical drilling blades also allow the experienced user to “actively” change direction during insertion to gain optimal orientation of the prosthetic connection, thereby facilitating the esthetic restoration process. The unique dual-function conical prosthetic connection, with hexagonal interlocking, supports a wide range of prosthetic options, including individually designed Procera® abutments and Procera® Implant Bridges Zirconia and Titanium. As with all Nobel Biocare products and solutions, NobelActive has undergone intensive mechanical and clinical testing:

• Mechanical testing has validated that NobelActive possesses the strength to withstand the rigors of occlusal loads.

• Nobel Biocare is currently running three consecutive prospective multi-center studies involving 19 centers, more than 300 patients, and more than 300 NobelActive implants. One-year results support the effectiveness of NobelActive.

• Prior to this launch, Nobel Biocare subjected NobelActive to an eight-month, intensive worldwide pre-launch with 2,000 experienced clinicians, with positive response from doctors involved.